Clinical trials have never been more ambitious. But ask anyone in the weeds, and they’ll tell you: execution hasn’t caught up with intent.
Contract Research Organizations (CROs) are being asked to deliver faster enrollments, more targeted cohorts, and richer data, on tighter budgets and timelines, with fewer staff, and under greater scrutiny. All while juggling outdated infrastructure and patchwork tools that weren’t built for today’s complexity. Just look at these stats:
- >50% of sites don’t meet enrollment goals
- Over 10% never activate at all
- Startup timelines now average 3 to 6 months
- And nearly 20% of studies fail entirely due to enrollment shortfalls
You don’t need more dashboards. You need different architecture.
Where the drag really happens
The digital trial era promised acceleration. But in reality, many “solutions” have just added layers of noise to an already chaotic process. CRO teams are forced to duct-tape together data sources, platforms, and workflows, while still manually stitching insights together with copy-paste and spreadsheets.
Clinical Research Coordinators (CRCs) aren’t burning out because they’re unmotivated; rather, they’re chasing false positives and combing through dead-end patient charts. The result?
- Feasibility crumbles mid-trial because it was based on outdated claims, not live clinical behavior
- Trial startup stalls because “automated” tools still need weeks of configuration and IT lift
You’re not behind because of talent or ambition. You’re behind because the core infrastructure of clinical research hasn’t evolved with the job.
What CROs deserve: Clinical intelligence that actually works
Let’s ditch the buzzwords. What’s really needed isn’t another dashboard or process; it’s clinical precision that fits inside your actual workflow.
At IMO Health, we don’t replace your tech stack, we strengthen it. We plug directly into the clinical backbone of care, surfacing the most relevant, high-fidelity signals at the exact moment they’re needed.
Feasibility that’s grounded in reality
Forget guesstimates and laggy claims. We map real, protocol-aligned patients from normalized electronic health record (EHR) data, so you see where the opportunity really is, from the start.
Here’s what you can expect:
- Clinically significant, condition-specific, normalized cohorts pulled directly from the clinical record
- Insights into aggregated provider behavior, not just historical codes
- Feasibility that holds up when the trial goes live
Enrollment acceleration that respects CRC time
We take the noise out of pre-screening and give CRCs precision from day one, resulting in:
- Maximum reduction in false positives
- Trial-eligible cohorts surfaced automatically within the EHR
- No logins, no wild goose chases, just clean, focused recruitment
Data capture that doesn’t steal weeks
CROs still rely on manual chart review when enrolling patients, but outdated workflows are costing trials critical time. Abstraction, reformatting, and transcription steps create unnecessary lag and the longer they take, the more costly and error-prone your trial becomes.
IMO Health streamlines the process by pulling trial-relevant data, structured and unstructured, directly from clinical notes. The result? Clean, normalized, protocol-aligned data that’s electronic data capture (EDC)-ready faster, with less manual lift.
Fewer steps. Better precision. Weeks to months reclaimed.
Site selection: The hidden cost center
Feasibility is only half the battle. Picking the wrong sites? That’s a silent killer of trial momentum and budget.
Every underperforming site drags down your enrollment curve, burns resources, and forces mid-trial rescue strategies that sponsors hate to see. Studies show that:
- Up to 80% of trials fail to meet enrollment deadlines
- The average cost of a non-activating site is over $40,000
- Each missed enrollment window can push timelines out by weeks or months
We fix that upstream. With IMO Health, you’re not only guessing based on old claims or self-reported trial experience. You’re selecting sites based on actual patient populations, enabling you to:
- Surface high-opportunity sites based on precision patient cohorts
- Avoid costly non-starters
- Align site choice with real-world patient presence and provider interest
By optimizing both where you run your trials and how you capture the data, you create a foundation that’s not just faster but smarter, more efficient, and far more resilient to mid-study surprises.
The real cost: Trust erosion you don’t see until it’s gone
The slow burn of invisible delays; two weeks lost in feasibility here, a month gone to manual validation, these all add up fast. And it doesn’t just kill time. It chips away at sponsor confidence.
In a post-M&A, post-pandemic world where every trial is high-stakes, trust is your competitive edge. And trust is built on precision, reliability, and repeatability.
What today’s sponsors want (and aren’t getting)
They’re not asking for more platforms. They’re asking for less guesswork. So, what wins requests for proposals (RFPs) now?
- Feasibility backed by live, protocol-matched clinical data
- Cohorting and pre-screening tools that work in days, not months
- Trial-ready data that’s structured before you ever touch the chart
- Less drag, less noise, less lift, for your team and theirs
Final take
CROs are fighting an uphill battle with yesterday’s tools.
IMO Health is the infrastructure upgrade clinical trials have been waiting for, built to reduce screen failures, speed up activation, and bring clean, validated data to the table with minimal manual lift.
Let others sell speed. We deliver precision, at the pace modern trials demand.
